Research Article

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis

Table 2

Frequencies of TPA I/D and PAI-1 4G/5G genotypes and alleles in MS patients and controls and uncorrected ORs for MS susceptibility.

Genotype/alleleSerbian cohortBH cohortPooled samples*
MS patients
(%)
Controls
(%)
OR
(95% CI)
MS patients
(%)
Controls
(%)
OR
(95% CI)
MS patients
(%)
Controls
(%)
OR
(95% CI)

TPA I/D
 II117 (30.6)98 (30.8)0.99 (0.72–1.37)0.95754 (31.8)42 (24.7)1.42 (0.88–2.28)0.149277 (31.3)261 (30.5)1.04 (0.85–1.27)0.715
 ID181 (47.4)134 (42.1)1.24 (0.92–1.67)0.16574 (43.5)87 (51.2)0.73 (0.48–1.13)0.158408 (46.1)367 (42.9)1.14 (0.94–1.38)0.176
 DD84 (22.0)86 (27.1)0.76 (0.54–1.01)0.12142 (24.7)41 (24.1)1.03 (0.63–1.70)0.899200 (22.6)228 (26.6)0.80 (0.65–1.00)0.050
Total382318170170885856

Allele I (%)415 (54.3)330 (51.9)1.10 (0.89–1.36)0.364182 (53.5)171 (50.3)1.14 (0.84–1.54)0.399962 (54.4)889 (52.0)1.10 (0.96–1.26)0.152
Allele D (%)349 (45.7)306 (48.1)0.91 (0.73–1.12)0.364158 (46.5)169 (49.7)0.88 (0.65–1.19)0.399808 (45.6)823 (48.0)0.91 (0.79–1.04)0.152

PAI 4G/5G
 4G4G118 (30.9)88 (27.7)1.17 (0.84–1.62)0.35341 (24.1)44 (25.9)0.91 (0.57–1.49)0.707245 (27.7)241 (28.1)0.98 (0.79–1.20)0.827
 4G5G182 (47.6)182 (57.2)0.68 (0.50–0.92)0.01297 (57.1)87 (51.2)1.27 (0.83–1.94)0.277457 (51.6)469 (54.8)0.88 (0.73–1.06)0.188
 5G5G82 (21.5)48 (15.1)1.54 (1.04–2.28)0.03232 (18.2)39 (22.9)0.78 (0.46–1.32)0.351183 (20.7)146 (17.1)1.27 (0.97–1.61)0.054
Total382318170170885856

Allele 4G (%)418 (54.7)358 (56.3)0.94 (0.76–1.16)0.554179 (52.6)175 (51.5)1.05 (0.78–1.42)0.759947 (53.5)951 (55.5)0.92 (0.80–1.05)0.225
Allele 5G (%)348 (45.3)278 (43.7)1.07 (0.86–1.32)0.554161 (47.4)165 (48.5)0.95 (0.71–1.29)0.759823 (46.5)761 (44.5)1.09 (0.95–1.24)0.225

Subjects analyzed in the current study (Serbian and BH) and subjects analyzed previously (Croatian and Slovenian) [12].